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Effects of Ethanol*
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The solvent, 2-ethoxyethanol, induced complete embryomortality in pregnant rats exposed to three times
the current Federal permissible exposure limit (PEL). Following exposure to ethoxyethanol at a
concentration only one-half the current PEL, the offspring evidenced behavioral and neurochemical
deviations from controls. Subsequent studies found that ingestion ofethanol with concomitant inhalation
of ethoxyethanol vapors early in pregnancy appeared to reduce the number of both behavioral and
neurochemical deviations found for ethoxyethanol. In contrast, the concomitant exposure to ethanol and
ethoxyethanol later in gestation potentiated the behavioral and neurochemical effects of ethoxyethanol.
This research indicates that the industrial solvent 2-ethoxyethanol presents an occupational reproductive
hazard and raises the issue ofthe importance ofan interaction ofsocial habits with occupational exposure
to such hazards. The results would suggest that occupational physicians should advise pregnant workers in
the chemical industry ofthe adverse effects of ethanol during pregnancy and of the possible interactions
with other chemicals and should encourage them to be especially cautious with ethanol consumption since
they may be at greater risk.
Concern over workplace contaminants which may
pose reproductive hazards has stimulated intensified
research into factors such as genetic defects, reduced
fertility, spontaneous abortions, infant deaths, and
malformations in the offspring of exposed subjects,
both in laboratory and epidemiological studies (1), as
recently reviewed (2). Ofgreatest concern are environ-
mental conditions which may preferentially jeopardize
reproduction in the absence of apparent toxicity to the
parent organism.
Nelson et al. (3) recently reported an example of an
industrialsolvent, 2-ethoxyethanol(Cellosolve, ethylene
glycol monoethyl ether), which altered fetal develop-
ment at much lower levels than those which affect the
mature organism. This chemical is produced and distri-
buted by at least six major American chemical compa-
nies and is widely used in industry (e.g., in lacquers,
dopes, inks, varnish removers, cleansing solutions and
resins). NIOSH estimates that approximately 365,000
American workers are exposed to ethoxyethanol, as are
consumers using some commercial products (e.g., cer-
tain cosmetics). Ethoxyethanol is relatively nontoxic,
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having an oral LD50 of 3 to 4 g/kg in most common
laboratory animal species (4). The lowest concentration
affecting laboratory animals via inhalation is on the
order of 2000 ppm for an 8-hr exposure (4), with blood
constituent changes followed by hepatic and renal
alterations. Its current Federal occupational permissi-
ble exposure limit is 200 ppm. Thus ethoxyethanol is
only moderately toxic to adult animals.
However, recent reports establish the fact that prena-
tal exposure of rats and rabbits to levels of 600 ppm
ethoxyethanol (7 hr/day) results in death ofall develop-
ing fetuses (3,5,6). Following prenatal exposure to
approximately 200 ppm ethoxyethanol, the current U.S.
occupational standard, offspring from both rats and
rabbits had an increased incidence ofcongenital malfor-
mations (5,6), and rats had increased neonatal deaths
(3). Concentrations one-halfthat level, lOOppm, did not
produce neonatal mortality, but did induce behavioral
and neurochemical deviations in the offspring of rats
(3). More recently, dermal exposure of rats to
ethoxyethanol was found to cause fetal wastage and
congenital malformations (7). Thus, it appears that
developing animals are susceptible to ethoxyethanol
toxicity atmuchlowerconcentrationsthanthoseproduc-
ingtoxicity inthe adult rat. In addition, close structural
analogs have also been found to produce embryo-
toxicity (8,9). Further, ethoxyethanol or close struc-
tural analogs have recently been shown to be muta-NELSON ET AL.
genic or to alter testicular function in experimental
animals (10-12). These latterfindings extend the appar-
ent impact of the ethoxyethanol results to other glycol
ethers and to both male and female reproductive
processes. Since ethoxyethanol would theoretically be
metabolized in a manner very similarto ethanol (i.e., by
alcohol and aldehyde dehydrogenase), we were inter-
ested in determining ifethanol would alter the prenatal
effects of ethoxyethanol. As ethanol is probably the
most commonly used (and abused) drug in our culture,
such interactive effects would have obvious implications
for occupationally related reproductive hazards. Two
possibilities were envisioned: ethanol would either re-
duce the prenatal effects by induction of hepatic
detoxification enzymes, i.e., an antagonistic type of
interaction; or it might enhance the prenatal effects
(since ethanol is itself a teratogen), i.e., a synergistic
typeofinteraction. Afterfirstestablishingthereproduc-
tive toxicology of ethoxyethanol as discussed above, a
second study was undertaken to investigate these
interaction possibilities. A concentration of ethanol
predicted to produce slight effects and the concentra-
tion ofethoxyethanol previously shown to produce clear
cut neuromotor and neurochemical effects in offspring
were chosen for the experiment.
Behavioral testing is thought to provide a more
sensitive technique for assessing prenatal toxicity than
standard teratological procedures (13). Accordingly,
this reserach utilized a number of behavioral measures
Table 1. Behavioral tests and days of testing in behavioral
teratology study (see text for explanation).
Age at which test
administered,
Behavioral test Function tested days
Ascent on wire mesh Neuromuscular integrity 10, 12, 14
Rotorod Neuromuscular integrity 21, 25, 29
Open field Exploratory activity 16, 17, 18; 30
31, 32, 44, 45,
46; 58, 59, 60
Activity wheel Circadian activity 32-33
Avoidance conditioning Aversive learning Begun days 34, 60
Operant conditioning Appetitive learning Begun day 40
Table 2. Neurochemical tests and days of testing (see text for
explanation).
Age at which
Neurochemical assay Site tested sample taken, days
Protein Whole brain Newborn
Acetylcholine
Dopamine
Norepinephrine
5-Hydroxytryptamine
Same chemicals Cerebrum 21
Cerebellum
Midbrain
Brainstem
designed to assess a variety of behaviors at several
stages in development, from neonates through sexually
mature subjects. The majority of these tests are fre-
quently used in similar studies (14). In addition, levels
of four common neurotransmitters were measured in
newborn animals and 21-day-old offspring, a time when
the development of several neurotransmitter systems
plateaus in developing rats. Tables 1 and 2 show the
different behavioral tests and neurochemical assays,
along with the test ages, included in this research.
Because of the extensive amount of data generated
from this study, details have been published elsewhere
(3,15,16). This report summarizes the results of the
research and presents the conclusions which can be
drawn from a synthesis of the data.
The experimental procedures were essentially identi-
cal in two experiments, the first on ethoxyethanol alone
(3), followed by a study including ethanol and
ethoxyethanol (15,16). Virgin Sprague-Dawley female
(200-300 g) rats were mated with breeders ofthe same
strain. Between 15 and 20 pregnant rats were assigned
to each ofthe following experimental groups represent-
ing the combination of conditions (ethanol, adminis-
tered in the drinking water, and ethoxyethanol adminis-
tered via inhalation, at different stages of gestation)
included in the two studies: (1) control (sham-exposed)
during gestation days 7-13 (C 7-13); (2) control (sham-
exposed) during gestation days 14-20 (C14-20); (3) 10%
ethanol (and sham-exposed) during gestation days 7-13
(E 7-13); (4) 10% ethanol (and sham-exposed) during
gestation days 14-20 (E 14-20); (5) 100 ppm
ethoxyethanol during gestation days 7-13 (100 EE
7-13); (6) 100 ppm ethoxyethanol during gestation days
14-20 (100 EE 14-20); (7) 10% ethanol and 100 ppm
ethoxyethanol during gestation days 7-13 (E + 100 EE
7-13); (8) 10% ethanol and 100 ppm ethoxyethanol
during gestation days 14-20 (E + 100 EE 14-20).
Pregnant rats were individaully housed in polycarbo-
nate cages with sawdust bedding, and feed and water
were available ad libitium, except for the groups given
ethanol. Animals were exposed to ethoxyethanol vapor
in 0.5 m3 exposure chambers with the exposure concen-
tration continuously monitored by an infrared analyzer
and verified at least weekly by a gas chromatograph.
Exposures were conducted 7 hr/day on gestation days
7-13 or 14-20. Alcohol (10% w/w) was giveninthe drink-
ing water during the time the animals were not in the
inhalation chambers. Followingbirth, litters were culled
to eight pups (four females and four males) which were
randomly assigned to test groups on-postnatal day 10.
One female and one male pup per litter were used for
each behavioral test (Table 1).
Atleasttenpupspertreatment groups were sacrificed
by focused microwave irradiation for neurochemical
analyses ofwhole-brain samples on the day ofbirth. An
equivalent number were sacrificed by focused micro-
wave irradiation on day 21, and the brains were
separatedintofourbrainregions(cerebrum, cerebellum,
brainstem, and midbrain). Assays on all samples used
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spectrofluorometric techniques (Table 2). Generally,
data were analyzed by multivariate analysis ofvariance,
but, in some selected cases, univariate or nonparamet-
ric techniques were more appropriate (3,15,16).
Results and Discussion
Tables 3 and 4 present a summary of the behavioral
and neurochemical results. Ethoxyethanol, whether
alone or in combination with ethanol, generally ex-
tended pregnancy duration, but ethanol alone did not.
Ethanol on gestation days 14-20 reduced maternal
weight gain, feed consumption, and liquid consumption.
Pup weights were not affected through the first 5 weeks
of life, the period over which they were measured.
Behavioral testing of pups showed that ethanol on
gestation days 7-13 was associated with advanced
neuromuscular ability on the ascent test, but with
poorerperformance on the rotorod. Other tests on these
pups showed no significant differences from controls.
Exposure to 100 ppm ethoxyethanol on gestation days
7-13 caused significant decreases in rotorod perfor-
mance on each test day and an increase in the latency of
leaving the central area of an open field. However, the
combination of ethoxyethanol and ethanol during the
same gestational period caused only two changes from
controls-a decrease in the number of shuttles in the
adaptation period of avoidance conditioning in young
rats but an increase in that parameter in older rats.
Thus, ethanol early in gestation appeared to reduce the
behavioral effects of ethoxyethanol, ameliorating the
neuromuscular effects of both exposures.
No behavioral differences were detected in offspring
of rats given ethanol alone on gestation days 14-20.
Maternal exposure to 100 ppm ethoxyethanol on gesta-
tion days 14-20 resulted in pups whose activity wheel
measures were depressed and whose performance was
retarded in avoidance conditioning. Following combined
exposure to ethoxyethanol and ethanol, different mea-
sures became affected. That is, open field activity was
depressed at each age tested, latency of leaving the
central area of the open field was increased, and the
number of shuttles in avoidance conditioning was de-
creased in pups of both ages-during the adaptation
period as well as during the conditioning trials
themselves. Thus, ethanol later in gestation appeared
to potentiate the behavioral effects of ethoxyethanol,
depressing both activity and learning.
In neurochemical assays, ethanol on gestation days
7-13 produced a single deviation from controls, viz., an
Table 3. Summary of the behavioral and maternal effects of ethanol, 2-ethoxyethanol and combined exposures on gestation days
7-13 or 14-20, relative to the respective controls.
E + EE E + EE
E 7-13 EE 7-13 7-13 E 14-20 EE 14-20 14-20
Maternal weight gain and feed and 4
water consumption
Pregnancy duration T t T
Behavioral tests
Ascent, day 10
12
14 t
Rotorod, day 21 4
25 4 4
29 4 4
Open field, La t
Day 17 4
31 4
45
59 4
Activity wheel
Day 4
Night 4
Avoidance conditioning
Young
CR-5b 4 4
CR-20C 4
Shocks
Older
CR-5b t I
CR-20c 4
Shocks t
Total deviations 4 4 3 1 4 10
aLatency.
bCrosses in 5-min warmup.
cCrosses in 20 trials.
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Table 4. Summary of the neurochemical effects of ethanol, 2-ethoxyethanol and combined exposures on gestation days 7-13 or 14-20.
100 EE E + 100 EE 100 EE E + 100
Site and compounda E 7-13 7-13 7-13 E 14-20 14-20 14-20
Cerebrum
Ach T T T
5Ht T
DA T T
NE T
Protein 4
Midbrain
Ach T T
5HT I
DA 4
NE t
Protein
Cerebellum
Ach T T
Ne
Brainstem
NE T
Newborn
Ach 4 4
5HT 4 4
DA 4 4 4
NE 4 4
Protein T
Total deviations 1 9 3 3 4 7
aSee Table 2.
increase in midbrain acetylcholine (ACh) in 21-day-old
pups. Exposure to 100 ppm ethoxyethanol alone on days
7-13 caused increases in cerebral ACh, dopamine (DA),
and norepinephrine (NE), midbrain ACh, NE, and
protein, cerebellar ACh, and brainstem NE in 21-day-
old pups, and decreases in NE in newborn pups. In
contrast, the combination of ethoxyethanol and ethanol
on days 7-13 resulted in fewer than one-half that
number of deviations: these were increases in cerebral
and cerebellar ACh in 21-day-old pups and decreases in
DA and 5HT in newborn pups. Thus, ethanol early in
gestation appeared to moderate the neurochemical
effects of ethoxyethanol.
Ethanol on gestation days 14-20 reduced levels of
DA, NE, and 5-hydroxytryptamine (5HT) in whole-
brain samples of newborn pups, but no significant
differences from control were seen in 21-day-old pups.
Exposure to 100 ppm ethoxyethanol alone on gestation
days 14-20 produced increased levels of cerebral ACh,
DA, and 5HT in 21-day-old pups, and decreased levels of
NE in newborn pups. Following combined exposure to
ethoxyethanol and ethanol, elevations in cerebral ACh
occurred along with decreases in cerebral protein and
midbrain ACh and 5HT in 21-day-old pups. There were
also decreases in ACh and DA, and increases in NE in
newborn pups. Overall, ethanol later in gestation al-
tered the pattern of and appeared to enhance the
neurochemical effects of ethoxyethanol.
Table 5 presents a summary of the number of effects
observed following exposure to ethoxyethanol alone and
when combined with ethanol. Ethanol early in gestation
appeared to reduce both the behavioral and neurochemi-
cal effects of ethoxyethanol, in that there were only
about one-half the number of deviations seen in the
Table 5. Summary of the number of effects following maternal
exposure toethoxyethanol alone orto ethoxyethanol andethanol.a
E +
E 100 EE 100 EE
Days 7-13
Maternal and behavioral 4 4 3
Neurochemical 1 9 3
Total 5 13 6
Days 14-20
Maternal and behavioral 1 4 10
Neurochemical 3 4 7
Total 4 8 17
aThe numbers included below are merely a summary ofdifferences
from control (fromTables 3 and 4). Maternal weight gain and feed and
liquid consumption are highly correlated; thus the group with
decreased values (E 14-20) was given a score of 1 on this variable. All
other counts were based on a score of 1 for each test day ofdifference
from control (e.g., ifrotorod performance were decreased on all three
days of testing, the score would be 3). We used this scoring system
because we believe that a consistent pattern of deviations should be
given a higher score than if only one day's score is different from
controls.
combination condition than were observed after
ethoxyethanol alone.* In contrast, ethanol later in
gestation produced over twice as many behavioral and
neurochemical alterations as ethoxyethanol alone, thus
appearing to potentiate the effects of ethoxyethanol
"The reduction in the number of defects after concomitant ethanol
administration should not be construed to imply that such an effect
would be encountered in humans. The point to be emphasized is that
an interactive effect was observed during both stages of gestation
examined.
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(the number of effects were not merely the additive
effects of each alone).
The reason a paradoxical prenatal interaction be-
tween ethoxyethanol and ethanol was observed is
unclear, and would certainly not be predicted. However,
the consistency in the patterns of behavioral and
neurochemical alterations is striking. It may be that the
different eventsinneuraltissue developmentatdifferent
gestation times could account for some of the effects
observed. Much of the neural system architecture is
formed early in gestation (corresponding to the early
exposure period), but neuron development and synapto-
genesis take place later in development. Thus it may
well be that the chemical interaction affected those
processes differently. Further, it is likely that placental
transport and biotransformation (17), and emerging
fetal biotransformation abilities (18-20) contributed to
the effects we observed. However, the mechanism by
which ethanol exerted its interaction with the prenatal
effects of ethoxyethanol remains to be elucidated.
Overall, the results indicate that 2-ethoxyethanol is
embryotoxic in experimental animals and that there
may be an interaction between ethanol and ethoxy-
ethanol. The clear implication of these results is that
women who work with this solvent would be especially
prudent to avoid drinking ethanol while pregnant.
Furthermore, our results raise the general possibility
that women who work with chemicals while pregnant
may place the developing fetus at substantially greater
risk through ethanol intake. Occupational physicians
should adopt a conservative view and advise women
who work with chemicals of the hazards of prenatal
ethanol consumption and encourage them to be cautious
since they may be at greater risk.
We thank Dr. Kent Anger for his careful and constructive review
ofthe manuscript and Mrs. Nadine Dickerson for her uncomplaining
work in typing and correcting the manuscript.
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